Hattingen, E., Bähr, O., Rieger, J., Blasel, S., Steinbach, J., & Pilatus, U. (2013). Phospholipid metabolites in recurrent glioblastoma: In vivo markers detect different tumor phenotypes before and under antiangiogenic therapy. Public Library of Science (PLoS).
Cita Chicago Style (17a ed.)Hattingen, Elke, Oliver Bähr, Johannes Rieger, Stella Blasel, Joachim Steinbach, y Ulrich Pilatus. Phospholipid Metabolites in Recurrent Glioblastoma: In Vivo Markers Detect Different Tumor Phenotypes Before and Under Antiangiogenic Therapy. Public Library of Science (PLoS), 2013.
Cita MLA (8a ed.)Hattingen, Elke, et al. Phospholipid Metabolites in Recurrent Glioblastoma: In Vivo Markers Detect Different Tumor Phenotypes Before and Under Antiangiogenic Therapy. Public Library of Science (PLoS), 2013.